458 related articles for article (PubMed ID: 16481822)
1. Osteonecrosis of the mandible or maxilla associated with the use of new generation bisphosphonates.
Farrugia MC; Summerlin DJ; Krowiak E; Huntley T; Freeman S; Borrowdale R; Tomich C
Laryngoscope; 2006 Jan; 116(1):115-20. PubMed ID: 16481822
[TBL] [Abstract][Full Text] [Related]
2. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
[TBL] [Abstract][Full Text] [Related]
3. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment.
Marx RE; Sawatari Y; Fortin M; Broumand V
J Oral Maxillofac Surg; 2005 Nov; 63(11):1567-75. PubMed ID: 16243172
[TBL] [Abstract][Full Text] [Related]
4. Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy.
Migliorati CA; Schubert MM; Peterson DE; Seneda LM
Cancer; 2005 Jul; 104(1):83-93. PubMed ID: 15929121
[TBL] [Abstract][Full Text] [Related]
5. Bisphosphonate-associated osteonecrosis: a clinician's reference to patient management.
Grewal VS; Fayans EP
Todays FDA; 2008 Aug; 20(8):38-41, 43-6. PubMed ID: 18767452
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases.
Grant BT; Amenedo C; Freeman K; Kraut RA
J Oral Maxillofac Surg; 2008 Feb; 66(2):223-30. PubMed ID: 18201600
[TBL] [Abstract][Full Text] [Related]
7. Jaw bone necrosis without previous dental extractions associated with the use of bisphosphonates (pamidronate and zoledronate): a four-case report.
Merigo E; Manfredi M; Meleti M; Corradi D; Vescovi P
J Oral Pathol Med; 2005 Nov; 34(10):613-7. PubMed ID: 16202082
[TBL] [Abstract][Full Text] [Related]
8. The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws.
Carlson ER; Basile JD
J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):85-95. PubMed ID: 19371819
[TBL] [Abstract][Full Text] [Related]
9. Bisphosphonate-induced osteonecrosis of the jaw.
Krueger CD; West PM; Sargent M; Lodolce AE; Pickard AS
Ann Pharmacother; 2007 Feb; 41(2):276-84. PubMed ID: 17299010
[TBL] [Abstract][Full Text] [Related]
10. Osteonecrosis of the maxilla and mandible in patients with advanced cancer treated with bisphosphonate therapy.
Estilo CL; Van Poznak CH; Wiliams T; Bohle GC; Lwin PT; Zhou Q; Riedel ER; Carlson DL; Schoder H; Farooki A; Fornier M; Halpern JL; Tunick SJ; Huryn JM
Oncologist; 2008 Aug; 13(8):911-20. PubMed ID: 18695259
[TBL] [Abstract][Full Text] [Related]
11. Bisphosphonate-induced necrosis of the jaws: a reconstructive nightmare.
Gevorgyan A; Enepekides DJ
Curr Opin Otolaryngol Head Neck Surg; 2008 Aug; 16(4):325-30. PubMed ID: 18626250
[TBL] [Abstract][Full Text] [Related]
12. Osteonecrosis of the jaw associated with bisphosphonate use: Presentation of seven cases and literature review.
Mortensen M; Lawson W; Montazem A
Laryngoscope; 2007 Jan; 117(1):30-4. PubMed ID: 17202926
[TBL] [Abstract][Full Text] [Related]
13. Avascular mandibular osteonecrosis in association with bisphosphonate therapy: a report on four patients.
Friedrich RE; Blake FA
Anticancer Res; 2007; 27(4A):1841-5. PubMed ID: 17649782
[TBL] [Abstract][Full Text] [Related]
14. ["Prevention and treatment of mandibular osteonecrosis due to bisphosphonates" -- interdisciplinary forum].
Olasz L; Szentirmay Z; Horvááth C; Poor G; Bucsi L; ; ; ;
Fogorv Sz; 2010 Mar; 103(1):27-8. PubMed ID: 20443355
[No Abstract] [Full Text] [Related]
15. Maxilla osseus sequestre and oral exposure: effects of the treatment of multiple myeloma with bisphosphonates.
Lobato JV; Rodrigues JM; Cavaleiro MV; Lobato JM; Xavier L; Santos JD; Maurício AC
Acta Med Port; 2007; 20(2):185-92. PubMed ID: 17868526
[TBL] [Abstract][Full Text] [Related]
16. Bisphosphonate induced osteonecrosis of the jaw masquerading as tumor: a word of caution for oral surgeons and oncologists.
Chaturvedi P; Pai PS; Chaukar DA; Gupta S; D'cruz AK
Eur J Surg Oncol; 2010 Jun; 36(6):541-5. PubMed ID: 20071132
[TBL] [Abstract][Full Text] [Related]
17. Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia.
Mavrokokki T; Cheng A; Stein B; Goss A
J Oral Maxillofac Surg; 2007 Mar; 65(3):415-23. PubMed ID: 17307586
[TBL] [Abstract][Full Text] [Related]
18. [Avascular necrosis of the jaw bone after bisphosphonate therapy].
Shlomi B; Levy Y; Kleinman S; Better H; Kahn A; Shtabsky A; Chaushu G
Harefuah; 2005 Aug; 144(8):536-9, 600, 599. PubMed ID: 16146148
[TBL] [Abstract][Full Text] [Related]
19. Osteonecrosis of the jaws in patients treated with bisphosphonates. Review of the literature and the Milan experience.
Oltolina A; Achilli A; Lodi G; Demarosi F; Sardella A
Minerva Stomatol; 2005; 54(7-8):441-8. PubMed ID: 16211002
[TBL] [Abstract][Full Text] [Related]
20. [Bisphosphonate-associated osteonecrosis of the jaws 1].
Allard RH; Lips P; Eekhoff EM; van Merkesteyn JP; van der Waal I
Ned Tijdschr Tandheelkd; 2007 Oct; 114(10):423-7. PubMed ID: 17972610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]